Granahan Investment Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Granahan Investment Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-44,467	Closed	-$2.95M	–	200
2021 Q3	$2.95M	Sell	44,467 -7,884	-15%	-$562K	0.06%	178
2021 Q2	$4.08M	Buy	52,351 +2,938	+6%	+$217K	0.08%	163
2021 Q1	$4.67M	Sell	49,413 -36,881	-43%	-$4.39M	0.1%	145
2020 Q4	$10.5M	Sell	86,294 -8,670	-9%	-$950K	0.24%	90
2020 Q3	$8.3M	Buy	+94,964	New	+$6.62M	0.28%	85

Other funds holding TPTX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Granahan Investment Management's TPTX Position: Q4 2021 in Review

Granahan Investment Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2021, closing a stake of 44,467 shares — an estimated $2.95M sold.

Granahan Investment Management first reported a position in TPTX in Q3 2020 and held it in 5 quarters. The position peaked at $10.5M in Q4 2020. 172 funds tracked by Wall St. Rank hold TPTX as of Q4 2021.

Granahan Investment Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Granahan Investment Management sold 44,467 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $2.95M.
Granahan Investment Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
Granahan Investment Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $10.5M in Q4 2020.
172 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.